Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,337 warrant series at 1,059 companies. 778 in the money, 58 expiring in the next 30 days, 38 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital Warrants (Sponsor) — $11.50, expiring 2029-09-26 | $1.17 | $8.3M | S-1, Jan 10, 2025Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2024 SPA common warrants (L1 Capital and Jutland Investments) | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| October 2023 SPA first-tranche investor warrants (likely) – $216.00 | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| October 2023 SPA second-tranche investor warrants – January 2, 2024 | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Spartan placement-agent warrants – October 2023 SPA first tranche | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Spartan placement-agent warrants – October 2023 SPA second tranche | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Underwriter (Spartan) IPO representative warrants – April 2023 | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Warrants at $1.80 (unidentified series; 20,000 at $0.20 on the pre-1-for-9 basis) | $1.56 | $8.3M | 10-Q, Sep 9, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Lender Warrant (Avenue, February 28, 2025; amended June 23, 2026) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| New Lender Warrant (Avenue, June 23, 2026) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Officer/Director Warrants (Private CalciMedica, October 2022) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Placement Agent Warrants (2024 Private Placement) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series A Warrants (June 2026 PIPE) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series B Warrants (June 2026 PIPE) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| SG 2024 Warrant (consultant affiliated with former interim CFO) | $1.22 | $8.3M | DEF 14A, Jul 23, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Tranche B Common Warrants (2024 Private Placement, investors) | $1.22 | $8.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Tranche B Common Warrants accompanying Placement Agent Warrants (JonesTrading) | $1.22 | $8.3M | S-3, Jan 31, 2024Dilution tabAs of Nov 11, 2026 | ||||||||
| Warrants issued in connection with convertible debenture agreements | $1.07 | $8.2M | 20-F, Mar 19, 2026Dilution tabAs of Oct 7, 2026 | ||||||||
| Broker warrants issued in 2026 convertible note and warrant offering ($3.48) | $0.6496 | $8.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| Series R Warrants issued with 2026 Convertible Debt Series A Notes ($3.20 investor warrants) | $0.6496 | $8.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 8, 2026 | ||||||||
| 2025 Warrants (July 2025 private placement, $23.00 post-split) | $1.61 | $8.2M | 10-Q, Nov 2, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| December 2025 Common Warrants | $5.08 | $8.2M | 10-K, Jun 10, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2025 Inducement Warrants | $5.08 | $8.2M | 10-K, Jun 10, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2025 Placement Agent Warrants | $5.08 | $8.2M | 10-K, Jun 10, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2026 Common Warrants | $5.08 | $8.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Legacy warrants at $46.40 (10-K price bucket) | $5.08 | $8.2M | 10-K, Jun 10, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2025 Common Warrants | $5.08 | $8.2M | 10-K, Jun 10, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2025 Placement Agent Warrants | $5.08 | $8.2M | 10-K, Jun 10, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2024 SPA Placement Agent Warrants ($1.15) — RBW Capital Partners / Dominari Securities | $0.1780 | $8.1M | S-1/A, Oct 21, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| December 2024 SPA Purchaser Warrants ($1.00) — Target Capital 14 LLC and Secure Net Capital LLC | $0.1780 | $8.1M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Warrants outstanding at December 31, 2023 (legacy block, incl. Titan placement agent and pre-2024 warrants) | $0.1780 | $8.1M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Placement Agent Warrants (Rodman & Renshaw, September 2024, $0.80) | $0.5711 | $8.1M | 10-K, Mar 12, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Pre-September 2024 warrants (aggregate, WAEP $6.38) | $0.5711 | $8.1M | POS AM, Oct 1, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| Series B Warrants (September 2024 offering, $0.64) | $0.5711 | $8.1M | S-1, Sep 14, 2026Dilution tabAs of Nov 3, 2026 | ||||||||
| April 2026 placement agent warrants | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| April 2026 warrants | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| December 2025 placement agent warrants | $0.9005 | $8.1M | 424B3, Jul 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| December 2025 private placement warrants | $0.9005 | $8.1M | 424B3, Jul 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2026 Long-term Warrants | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2026 placement agent warrants | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| June 2026 Short-term Warrants | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 18, 2025 private placement warrants | $0.9005 | $8.1M | 424B3, Jul 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 24, 2025 placement agent warrants | $0.9005 | $8.1M | 424B3, Jul 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 24, 2025 private placement warrants | $0.9005 | $8.1M | 424B3, Jul 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-funded warrants outstanding (aggregate, November 2025 and June 2026 series) | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| September 15, 2026 Khoja private placement warrants | $0.9005 | $8.1M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B-1 preferred-related warrants (legacy) | $0.9005 | $8.1M | 424B3, Jul 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2026 PIPE Options (Class B Option Shares, US$3.18) | $3.13 | $8.1M | 6-K, Oct 23, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Private Placement Warrants (former Tristar private warrants assumed by Helport AI) | $0.2020 | $8.1M | 20-F, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Public Warrants (former Tristar public warrants assumed by Helport AI) | $0.2020 | $8.1M | 20-F, Nov 16, 2026Dilution tabAs of Nov 17, 2026 |
FOXXFoxx Development Holdings Inc.$1.17Last price
Working Capital Warrants (Sponsor) — $11.50, expiring 2029-09-26
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
June 2024 SPA common warrants (L1 Capital and Jutland Investments)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
October 2023 SPA first-tranche investor warrants (likely) – $216.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
October 2023 SPA second-tranche investor warrants – January 2, 2024
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
Spartan placement-agent warrants – October 2023 SPA first tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
Spartan placement-agent warrants – October 2023 SPA second tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
Underwriter (Spartan) IPO representative warrants – April 2023
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
TPETTrio Petroleum Corp.$1.56Last price
Warrants at $1.80 (unidentified series; 20,000 at $0.20 on the pre-1-for-9 basis)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Lender Warrant (Avenue, February 28, 2025; amended June 23, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
New Lender Warrant (Avenue, June 23, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Officer/Director Warrants (Private CalciMedica, October 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Placement Agent Warrants (2024 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Series A Warrants (June 2026 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Series B Warrants (June 2026 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
SG 2024 Warrant (consultant affiliated with former interim CFO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Tranche B Common Warrants (2024 Private Placement, investors)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
CALCCalciMedica, Inc.$1.22Last price
Tranche B Common Warrants accompanying Placement Agent Warrants (JonesTrading)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.3M
ALARAlarum Technologies Ltd. American Depositary Share$1.07Last price
Warrants issued in connection with convertible debenture agreements
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
BRFHBarfresh Food Group Inc.$0.6496Last price
Broker warrants issued in 2026 convertible note and warrant offering ($3.48)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
BRFHBarfresh Food Group Inc.$0.6496Last price
Series R Warrants issued with 2026 Convertible Debt Series A Notes ($3.20 investor warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
OPADOfferpad Solutions Inc.$1.61Last price
2025 Warrants (July 2025 private placement, $23.00 post-split)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
December 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
December 2025 Inducement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
December 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
July 2026 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
Legacy warrants at $46.40 (10-K price bucket)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
September 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
AEMDAethlon Medical, Inc.$5.08Last price
September 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.2M
CISOCISO Global Inc.$0.1780Last price
December 2024 SPA Placement Agent Warrants ($1.15) — RBW Capital Partners / Dominari Securities
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
CISOCISO Global Inc.$0.1780Last price
December 2024 SPA Purchaser Warrants ($1.00) — Target Capital 14 LLC and Secure Net Capital LLC
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
CISOCISO Global Inc.$0.1780Last price
Warrants outstanding at December 31, 2023 (legacy block, incl. Titan placement agent and pre-2024 warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
SYRASyra Health Corp. Class A Common Stock$0.5711Last price
Placement Agent Warrants (Rodman & Renshaw, September 2024, $0.80)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
SYRASyra Health Corp. Class A Common Stock$0.5711Last price
Pre-September 2024 warrants (aggregate, WAEP $6.38)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
SYRASyra Health Corp. Class A Common Stock$0.5711Last price
Series B Warrants (September 2024 offering, $0.64)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
April 2026 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
April 2026 warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
December 2025 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
December 2025 private placement warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
June 2026 Long-term Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
June 2026 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
June 2026 Short-term Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
November 18, 2025 private placement warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
November 24, 2025 placement agent warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
November 24, 2025 private placement warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
Pre-funded warrants outstanding (aggregate, November 2025 and June 2026 series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
September 15, 2026 Khoja private placement warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
FBLGFibroBiologics, Inc. Common Stock$0.9005Last price
Series B-1 preferred-related warrants (legacy)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
BANLCBL International Limited Class B Ordinary Shares$3.13Last price
October 2026 PIPE Options (Class B Option Shares, US$3.18)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
HPAIHelport AI Limited Ordinary Shares$0.2020Last price
Private Placement Warrants (former Tristar private warrants assumed by Helport AI)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
HPAIHelport AI Limited Ordinary Shares$0.2020Last price
Public Warrants (former Tristar public warrants assumed by Helport AI)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$8.1M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,078 dilution snapshots. 4,883 of 5,337 series state an exercise price and 3,370 an expiry date. 247 record when exercise begins; that count grows as companies are re-extracted. 625 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.